PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses of body fluids to determine ceruplasmin (CER), the principal copper-containing protein in human plasma and one of the acute-phase reactants. Decreased levels of ceruplasmin combined with increased copper concentration are associated with an inherited disease characterized by a defect in the metabolism of copper (Wilson\'s disease, also called hepatolenticular degeneration). Increased CER levels are common in infections, trauma, biliary duct obstruction, and Hodgkin\'s disease.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3691831_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3691831_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all